Halozyme Therapeutics reported $785.57M in Loan Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Agios Pharmaceuticals AGIO:US $ 0.17M 0.08M
Alnylam Pharmaceuticals ALNY:US $ 433.15M 241.56M
Amarin AMRN:US $ 0M 0M
Amgen AMGN:US $ 28458M 2671M
Aptinyx Inc APTX:US $ 0 0
Arena Pharmaceuticals ARNA:US $ 38.78M 1.25M
Baxter International BAX:US $ 5710M 29M
Cara Therapeutics CARA:US $ 0 0
Cytokinetics CYTK:US $ 127.89M 3.88M
Eli Lilly And LLY:US $ 14736.6M 1463M
Esperion Therapeutics ESPR:US $ 272.1M 404K
Halozyme Therapeutics HALO:US $ 785.57M 0.84M
Immunogen IMGN:US $ 0M 0M
Intercept Pharmaceuticals ICPT:US $ 575.82M 7.7M
Intra Cellular Therapies ITCI:US $ 0M 0M
IONIS PHARMACEUT IONS:US $ 1240.7M 369.78M
JAZZ PHA JAZZ:US $ 6495.33M 4642.3M
Mannkind MNKD:US $ 280.26M 45.66M
Minerva Neurosciences NERV:US $ 0M 0M
Nektar Therapeutics NKTR:US $ 0M 0M
Peregrine Pharmaceuticals PPHM:US $ 138.81M 41.86M
Rigel Pharmaceuticals RIGL:US $ 19.86M 0.02M
United Therapeutics UTHR:US $ 800M 0M
Vanda Pharmaceuticals VNDA:US $ 0M 0M